REGENERATION OF INJURED SPINAL CORD
BY ELECTRO PULSED BIO-HYBRID APPROACH
Evocative image of the project activity

RISEUP at the 5th World Congress on Electroporation: Booth and Special Session Highlight Advances in Spinal Cord Injury Research

During the 5th World Congress on Electroporation, held on Tuesday, 17th September, the RISEUP project made a significant impact through a dedicated booth and a special session organized by project partners UNIROMA1 and ENEA.

Showcasing RISEUP Technology at the Booth 14

The RISEUP booth, generously supported by UNIROMA1, provided an engaging platform to showcase the project's cutting-edge technology. Visitors were introduced to the project’s objectives and latest advancements through interactive displays, detailed posters, and expert insights from consortium members. The booth (Fig. 1) served as an excellent opportunity to disseminate the results of the past three years of research and foster engagement with attendees interested in novel strategies for spinal cord injury treatment.

Fig. 1. The RISEUP booth at the 5th World Congress on Electroporation. (A) Group picture of CNRS, UNIROMA1 and ENEA members gathered around the booth. (B) The booth set-up. (C) A detail of the in vitro EPB exhibited in the booth.

Special Session: “Treatment of Spinal Cord Injury: Novel Strategies and Updates from the RISEUP Project”

A key highlight of the congress was the special session titled “Treatment of Spinal Cord Injury: Novel Strategies and Updates from the RISEUP Project”. Organized by UNIROMA1 and ENEA, this session featured presentations by consortium members as well as renowned external experts in the field (Fig. 2):

  • Prof. Salvatore Aglioti: Distinguished neuroscientist and professor from Sapienza University of Rome, specialized in the neural mechanisms of sensorimotor and cognitive functions and their recovery in patients with neurological conditions.
  • Dr. Mark Anderson: The Chief Scientific Officer at the Wyss Center for Bio and Neuroengineering, Dr. Anderson is a leading expert in neurotechnologies and their applications in diagnosing, monitoring, and treating neurological disorders, including spinal cord injuries. His work bridges cutting-edge research and clinical translation.
  • Dr. Simona Salati: Representing IGEA, Dr. Salati is an expert in bioelectromagnetic therapies, focusing on the development and application of electroporation techniques for medical treatments, including regenerative therapies.
Fig.2. Flyer of the RISEUP Special Session

Special Session: “Treatment of Spinal Cord Injury: Novel Strategies and Updates from the RISEUP Project”

These speakers enriched the session with valuable insights from their respective areas of expertise, complementing the RISEUP consortium’s updates with broader perspectives on cutting-edge research and clinical applications.

The session showcased RISEUP’s latest results, while also highlighting broader innovations in the field. A large and engaged audience further emphasized the importance of the topics discussed, creating a fertile ground for scientific exchange and discussion. Pictures highlighting moments of the special sessions are shown in Fig. 3.

Fig. 3A. The special session’s speakers presenting their cutting edge results.
Fig. 3B. Glances of the fruitful exchanges during the special session.

Building Foundations for Future Collaborations

The vibrant exchange of ideas during the session and at the booth highlighted the potential for cross-disciplinary collaborations. These interactions are expected to strengthen the project's momentum and pave the way for future partnerships in the field of advanced spinal cord injury therapies.

CONSORTIUM

ENEA - Italian National Agency for New Technologies, Energy and Sustainable Economic Development
Universitat Politècnica de València
RISE TECHNOLOGY SRL
Sapienza University of Rome
 Centre national de la recherche scientifique
CIPF: Prince Felipe Research Centre
The European Commission's website

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 964562

feedback